Drug Side Effects
Search
ADENOSQUAMOUS CARCINOMA OF THE CERVIX
ADENOSQUAMOUS CARCINOMA OF THE CERVIX
was reported 18 times
ADENOSQUAMOUS CARCINOMA OF THE CERVIX is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Antisense Oligonucleotide [EPC]
1
0.0001
1
Provitamin D2 Compound [EPC]
2
0.0001
2
Pyrimidine Synthesis Inhibitor [EPC]
1
0.0000
3
Aromatase Inhibitor [EPC]
2
0.0000
4
Proteasome Inhibitor [EPC]
2
0.0000
5
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
2
0.0000
6
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
2
0.0000
7
Glycopeptide Antibacterial [EPC]
1
0.0000
8
Alkylating Drug [EPC]
3
0.0000
9
Integrin Receptor Antagonist [EPC]
1
0.0000
10
Platinum-based Drug [EPC]
3
0.0000
11
Vascular Endothelial Growth Factor Inhibitor [EPC]
2
0.0000
12
Nucleoside Metabolic Inhibitor [EPC]
2
0.0000
13
Leukocyte Growth Factor [EPC]
1
0.0000
14
Microtubule Inhibitor [EPC]
1
0.0000
15
Interferon beta [EPC]
1
0.0000
16
Mood Stabilizer [EPC]
1
0.0000
17
Thalidomide Analog [EPC]
2
0.0000
18
Dihydropyridine Calcium Channel Blocker [EPC]
1
0.0000
19
Proton Pump Inhibitor [EPC]
1
0.0000
20
Corticosteroid [EPC]
2
0.0000
21
Nonsteroidal Anti-inflammatory Drug [EPC]
2
0.0000